Mutation analysis of ASXL1, CBL, DNMT3A, IDH1, IDH2, JAK2, MPL, NF1, SF3B1, SUZ12, and TET2 in myeloproliferative neoplasms. (Q54518446)

30 May 2018

title

Mutation analysis of ASXL1, CBL, DNMT3A, IDH1, IDH2, JAK2, MPL, NF1, SF3B1, SUZ12, and TET2 in myeloproliferative neoplasms. (English)

1 reference

30 May 2018

12

Borhane Slama

1 reference

30 May 2018

author name string

Mandy Brecqueville

1

1 reference

30 May 2018

Jérôme Rey

2

1 reference

30 May 2018

François Bertucci

3

1 reference

30 May 2018

Emilie Coppin

4

1 reference

30 May 2018

Pascal Finetti

5

1 reference

30 May 2018

Nadine Carbuccia

6

1 reference

30 May 2018

Nathalie Cervera

7

1 reference

30 May 2018

Véronique Gelsi-Boyer

8

1 reference

30 May 2018

Christine Arnoulet

9

1 reference

30 May 2018

Olivier Gisserot

10

1 reference

30 May 2018

Denis Verrot

11

1 reference

30 May 2018

Norbert Vey

13

1 reference

30 May 2018

Marie-Joelle Mozziconacci

14

1 reference

30 May 2018

Daniel Birnbaum

15

1 reference

30 May 2018

Anne Murati

16

1 reference

30 May 2018

publication date

9 April 2012

1 reference

30 May 2018

Genes, Chromosomes and Cancer

published in

1 reference

30 May 2018

volume

51

1 reference

30 May 2018

issue

8

1 reference

30 May 2018

page(s)

743-755

1 reference

30 May 2018

Genetic analysis of transforming events that convert chronic myeloproliferative neoplasms to leukemias

cites work

1 reference

DNMT3A mutational analysis in primary myelofibrosis, chronic myelomonocytic leukemia and advanced phases of myeloproliferative neoplasms

21 January 2018

1 reference

Concomitant analysis of EZH2 and ASXL1 mutations in myelofibrosis, chronic myelomonocytic leukemia and blast-phase myeloproliferative neoplasms

21 January 2018

1 reference

Rare mutations in DNMT3A in myeloproliferative neoplasms and myelodysplastic syndromes.

21 January 2018

1 reference

Mutations and deletions of the SUZ12 polycomb gene in myeloproliferative neoplasms

21 January 2018

1 reference

Mutations of ASXL1 gene in myeloproliferative neoplasms.

21 January 2018

1 reference

Mutual exclusion of ASXL1 and NPM1 mutations in a series of acute myeloid leukemias.

21 January 2018

1 reference

Additional sex comb-like 1 (ASXL1), in cooperation with SRC-1, acts as a ligand-dependent coactivator for retinoic acid receptor

21 January 2018

1 reference

Mutation in TET2 in myeloid cancers

21 January 2018

1 reference

Molecular aspects of myeloproliferative neoplasms.

21 January 2018

1 reference

Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders

21 January 2018

1 reference

Characterization of Asxl1, a murine homolog of Additional sex combs, and analysis of the Asx-like gene family

21 January 2018

1 reference

DIPSS plus: a refined Dynamic International Prognostic Scoring System for primary myelofibrosis that incorporates prognostic information from karyotype, platelet count, and transfusion status

21 January 2018

1 reference

Frequent CBL mutations associated with 11q acquired uniparental disomy in myeloproliferative neoplasms

21 January 2018

1 reference

DNMT3A Mutations in Acute Myeloid Leukemia

21 January 2018

1 reference

Mutations of e3 ubiquitin ligase cbl family members constitute a novel common pathogenic lesion in myeloid malignancies.

21 January 2018

1 reference

TET2, ASXL1, IDH1, IDH2, and c-CBL genes in JAK2- and MPL-negative myeloproliferative neoplasms

21 January 2018

1 reference

ASXL1 mutations identify a high-risk subgroup of older patients with primary cytogenetically normal AML within the ELN Favorable genetic category

21 January 2018

1 reference

Somatic mutations of the histone methyltransferase gene EZH2 in myelodysplastic syndromes

21 January 2018

1 reference

Myeloid blastic transformation of myeloproliferative neoplasms—A review of 112 cases

21 January 2018

1 reference

Novel mutations in the inhibitory adaptor protein LNK drive JAK-STAT signaling in patients with myeloproliferative neoplasms.

21 January 2018

1 reference

Janus kinase 2 mutations in Philadelphia negative chronic myeloproliferative disorders: clinical implications

21 January 2018

1 reference

Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts

21 January 2018

1 reference

IDH1 and IDH2 mutation analysis in chronic- and blast-phase myeloproliferative neoplasms.

21 January 2018

1 reference

LNK mutation studies in blast-phase myeloproliferative neoplasms, and in chronic-phase disease with TET2, IDH, JAK2 or MPL mutations

21 January 2018

1 reference

MPLW515L is a novel somatic activating mutation in myelofibrosis with myeloid metaplasia

21 January 2018

1 reference

ASXL1 mutations in primary and secondary myelofibrosis.

21 January 2018

1 reference

Combined mutations of ASXL1, CBL, FLT3, IDH1, IDH2, JAK2, KRAS, NPM1, NRAS, RUNX1, TET2 and WT1 genes in myelodysplastic syndromes and acute myeloid leukemias

21 January 2018

1 reference

Histone H2A deubiquitinase activity of the Polycomb repressive complex PR-DUB

21 January 2018

1 reference

Inactivation of polycomb repressive complex 2 components in myeloproliferative and myelodysplastic/myeloproliferative neoplasms.

21 January 2018

1 reference

JAK2 exon 12 mutations in polycythemia vera and idiopathic erythrocytosis

21 January 2018

1 reference

Sex differences in the JAK2 V617F allele burden in chronic myeloproliferative disorders.

21 January 2018

1 reference

Disruption of the ASXL1 gene is frequent in primary, post-essential thrombocytosis and post-polycythemia vera myelofibrosis, but not essential thrombocytosis or polycythemia vera: analysis of molecular genetics and clinical phenotypes

21 January 2018

1 reference

Spectrum of mutations in RARS-T patients includes TET2 and ASXL1 mutations

21 January 2018

1 reference

Novel mutations and their functional and clinical relevance in myeloproliferative neoplasms: JAK2, MPL, TET2, ASXL1, CBL, IDH and IKZF1

21 January 2018

1 reference

Primary myelofibrosis: 2012 update on diagnosis, risk stratification, and management

21 January 2018

1 reference

TET2 mutations and their clinical correlates in polycythemia vera, essential thrombocythemia and myelofibrosis

21 January 2018

1 reference

IDH1 and IDH2 mutation studies in 1473 patients with chronic-, fibrotic- or blast-phase essential thrombocythemia, polycythemia vera or myelofibrosis.

21 January 2018

1 reference

The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes

21 January 2018

1 reference

Frequent pathway mutations of splicing machinery in myelodysplasia

21 January 2018

1 reference

Myelodysplastic syndromes: lost between two states?

21 January 2018

1 reference

7 January 2021

Frequent mutation of the polycomb-associated gene ASXL1 in the myelodysplastic syndromes and in acute myeloid leukemia

1 reference

7 January 2021

Distinct clinical and biological features of de novo acute myeloid leukemia with additional sex comb-like 1 (ASXL1) mutations

1 reference

7 January 2021

ASXL1 mutation is associated with poor prognosis and acute transformation in chronic myelomonocytic leukaemia

1 reference

7 January 2021

Deletion of the tumor-suppressor gene NF1 occurs in 5% of myeloid malignancies and is accompanied by a mutation in the remaining allele in half of the cases

1 reference

7 January 2021

SF3B1 mutations in primary myelofibrosis: clinical, histopathology and genetic correlates among 155 patients

1 reference

7 January 2021

DNMT3A mutations in myeloproliferative neoplasms

1 reference

7 January 2021

Mutation in TET2 in myeloid cancers

1 reference

7 January 2021

SF3B1, a splicing factor is frequently mutated in refractory anemia with ring sideroblasts

1 reference

7 January 2021

Identifiers

DOI

10.1002/GCC.21960

1 reference

30 May 2018

1 reference

30 May 2018